A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for mirvetuximab soravtansine (an antibody-drug conjugate therapy), emphasizing ...
Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...
We tried out one of the most advanced baseline diagnostic panels available – here’s what we discovered about our health with this biomarker testing… Preventative healthcare has long been the preserve ...
FOX61 on MSNOpinion
Connecticut cancer survivors advocate in Hartford for more biomarker testing
If more extensively insured, the cutting-edge treatment could reduce health disparities for cancer patients and improve ...
(Denver, Colo.—July 14, 2025) -- A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP) and the Early Detection & Screening ...
Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...
Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...
TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic claims The 500+ gene biomarker test advances ...
CHICAGO, Nov. 19, 2024 /PRNewswire/ -- Lung cancer is the leading cause of the cancer deaths in the U.S., but the American Lung Association's 2024 "State of Lung Cancer" report reveals positive news.
Superpower, the company empowering members to take control of their health, today announces the launch of the world’s first health super-app—beginning with the most comprehensive biomarker testing ...
Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations. Biomarker testing for patients with lung cancer is critical, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback